Ranking Profile - Chembio Diagnostic Inc

Introduction

Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases including COVID-19, sexually transmitted disease, and fever and tropical disease. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers products to medical laboratories and hospitals, governmental, non-governmental organizations, and public health entities, medical professionals and retailers. The company distributes products through a network of distributors worldwide. Chembio is headquartered in Hauppauge, New York, the US.